Carson Wealth (CWM LLC)
ORKA

Carson Wealth (CWM LLC)’s Oruka Therapeutics ORKA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.8K Sell
424
-162
-28% -$5.63K ﹤0.01% 4386
2025
Q4 		$18K Buy
586
+192
+49% +$5.35K ﹤0.01% 4242
2025
Q3 		$8K Buy
+394
New +$5.84K ﹤0.01% 4595

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ORKA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Oruka Therapeutics (ORKA) stake by 28% in Q1 2026, selling an estimated $5.63K and leaving 424 shares worth $20.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4386.

Carson Wealth (CWM LLC) first reported a position in ORKA in Q3 2025 and has held it in 3 quarters since. 184 funds tracked by Wall St. Rank hold ORKA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 424 shares of Oruka Therapeutics worth $20.8K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 162 Oruka Therapeutics shares in Q1 2026, an estimated $5.63K.
  • Oruka Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4386 holding.
  • Carson Wealth (CWM LLC) first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 184 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.